RiboGene, Inc. Shares Recommended by WallStreet Research HAYWARD, Calif., Sept. 29, 1999 (PRIMEZONE) - RiboGene, Inc. (AMEX:RBO) shares have recently been recommended in an analyst report just released by WallStreet Research, a prominent research boutique...

Donner Corp. International Reiterates Strong Buy Recommendation on Cypros Pharmaceutical Based on News of Merger with Ribogene SANTA ANA, Calif., Aug. 5, 1999 (PRIMEZONE) -- The following is being issued by Donner Corporation International, a member of the National Association of Securities Dealers, CRD number...

Ribogene to Appear at the Wall Street Forum Boston Conference June 3 HAYWARD, Calif., May 28, 1999 (PRIMEZONE) -- RiboGene Inc. (AMEX: RBO), a biotechnology company focused on the discovery and development of novel therapeutics for the treatment of infectious diseases...

RiboGene, Inc. Shares Recommended by WallStreet Research HAYWARD, Calif. - Dec. 2, 1998 (PRIMEZONE) - RiboGene, Inc. (AMEX:RBO), announced that the Company's shares have recently been recommended in an analyst report released by WallStreet Research, a...